BIOEMTECH

BIOEMTECH is a CRO that aims to bridge the gap between ex vivo studies and in vivo molecular imaging, by providing cost effective solutions in terms of instrumentation and services. BIOEMTECH has developed and commercialized the eyes, the first desktop cameras, suitable for whole body, real time imaging of PET and SPECT isotopes in mice. In addition, BIOEMTECH undertakes full studies for evaluating new compounds in our authorized laboratories that include animal facility, in vitro lab, radiochemistry lab and in vivo imaging with microPET/SPECT/CT and optical imaging. Our clients include both Universities and Pharma companies. Finally, BIOEMTECH is rather active...

Small animal imaging,dedicated imaging systems,radiolabeling of biomolecules and nanoparticles,anthropomorphic phantoms,computer simulations,nanomedicine,nanotechnology,molecular imaging,nuclear medicine,radiopharmaceuticals,cro,pharmacokinetics,in vivo imaging,in vitro studies,pharmaceuticals,and bioimaging

Bioemtech's revenue is 11m - 100m

Bioemtech has 11 - 50 employees.